Today: 11 June 2026
Applied Digital stock slides, then swings hard as new Buy call pegs $42 target — what’s next for APLD
22 January 2026
1 min read

Applied Digital stock slides, then swings hard as new Buy call pegs $42 target — what’s next for APLD

New York, January 21, 2026, 19:54 (EST) — After-hours

  • Applied Digital ended the day 1.1% lower at $35.06, following a volatile session.
  • Texas Capital kicked off coverage, assigning a Buy rating and setting a $42 price target
  • Investors await new lease and financing news related to its AI data-center expansion

Applied Digital (APLD.O) shares dipped 1.1%, finishing Wednesday at $35.06. Earlier, the stock swung between $38.00 and $32.33. Volume hit roughly 42.1 million shares.

The stock now acts as a stand-in for a tight race: who can grab power, scale quickly, and lock in lengthy contracts for AI workloads. Even minor news can trigger shifts, and the volatility runs both directions.

This matters because the market is valuing future megawatts — the power capacity that determines how many servers a data center can support — well before the facilities are operational. Investors keep coming back to one key issue: execution and the funding behind it.

Texas Capital’s Derrick Whitfield kicked off coverage with a Buy rating and set a $42 price target, highlighting the company’s “waterless cooling” technology and its land-and-power portfolio, which could reach up to 4.3 gigawatts. TipRanks

Applied Digital is positioning itself as an “AI Factory” developer in North Dakota, focusing on long-term leases for high-performance computing (HPC), the intensive processing needed for AI model training and operation. In its latest quarterly update earlier this month, the company reported 600 megawatts leased across two campuses, including a 400-MW buildout for CoreWeave and a nearly 15-year, 200-MW lease with another investment-grade hyperscaler. It also highlighted major financing moves, like a $2.35 billion private notes offering and preferred equity draws with Macquarie, to support ongoing construction. Applied Digital Corporation

But the trade isn’t straightforward. The stock trades as if it’s a developer with locked-in tenants and set delivery timelines. The risks are well-known: construction hold-ups, delayed customer approvals, or rising financing costs that eat into returns before cash flow kicks in.

Timing also remains a hurdle. The investor relations calendar lists no events on the horizon, pushing traders to sift through filings, track project milestones, and watch for new lease disclosures to gauge momentum.

The next major event to watch is Applied Digital’s upcoming earnings report. Zacks and other market trackers have April 13, 2026, penciled in for the release, even though the company hasn’t officially confirmed a date on its own calendar.

Stock Market Today

  • TIG Advisors Reduces Stake in Beazley PLC by 330,000 Shares
    June 11, 2026, 10:47 AM EDT. TIG Advisors, LLC, acting as discretionary investment manager for AlTi Global, Inc., disclosed a reduction in its long position in Beazley PLC's shares. After the deal on June 10, 2026, it held 5,928,546 derivative shares, representing 0.99% of Beazley's total securities (ISIN: GB00BYQ0JC66). The transaction involved selling 330,000 5p ordinary shares at a price of 1,283.00 pence per unit. The disclosure was made under Rule 8.3 of the UK's Takeover Code, which requires revealing interests exceeding 1% in relevant securities. This transaction signals a strategic portfolio adjustment by TIG Advisors in the insurance firm's equity.

Latest articles

Theriva Biologics Pops on VCN-01 Study Results, Gets Traders’ Attention

Theriva Biologics Pops on VCN-01 Study Results, Gets Traders’ Attention

11 June 2026
TOVX soared 74.6% to $0.4252 after Theriva Biologics published Phase 1 VCN-01 data showing survival and biomarker signals in head-and-neck cancer, but the jump was not due to drug approval or revenue; investors face ongoing financing, dilution, and clinical-trial execution risks, with the company’s cash runway only into Q1 2027 and substantial doubt about its ability to continue as a going concern without new capital.
Trulieve Stock Turns Heads on NYSE After $50 Million Buyback

Trulieve Stock Turns Heads on NYSE After $50 Million Buyback

11 June 2026
Trulieve began NYSE trading as TRLV this week after moving from OTC/CSE, authorized a buyback of up to $50 million or 8.5 million shares, and closed its first NYSE session at $11.50, down 0.43%, before trading near $11.78 early Thursday, as investors weigh whether the uplisting and buyback will boost demand amid ongoing federal cannabis policy uncertainty.
Propanc Biopharma Jumps on $5 Million Buyback Plan, Investors React

Propanc Biopharma Jumps on $5 Million Buyback Plan, Investors React

11 June 2026
Propanc Biopharma shares soared as much as 392% after authorizing up to $5 million in stock buybacks—exceeding its prior $3.1 million equity value—even as it reported just $443,702 in cash and flagged going-concern risks, with investors now focused on whether its lead cancer drug PRP will advance to a planned Phase 1b trial this year.
Applied Materials stock rebounds after tariff scare fades; what to watch next for AMAT
Previous Story

Applied Materials stock rebounds after tariff scare fades; what to watch next for AMAT

Compass Group shares rise in early London trade: what the CPG stock price move says ahead of Feb 5 update
Next Story

Compass Group shares rise in early London trade: what the CPG stock price move says ahead of Feb 5 update

Go toTop